Published in Hum Pathol on May 01, 1988
Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol (1992) 3.43
Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling. Proc Natl Acad Sci U S A (2008) 2.98
Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J Cell Biol (1990) 1.88
Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas. Am J Pathol (1990) 1.65
Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am J Pathol (1996) 1.35
Primary clear cell carcinoma of noncirrhotic liver: immunohistochemical discrimination of hepatocellular and cholangiocellular origin. Dig Dis Sci (1998) 1.12
Cell behavior in the acetylaminofluorene-treated regenerating rat liver. Light and electron microscopic observations. Am J Pathol (1994) 1.06
Hepatic progenitor cells in human liver tumor development. World J Gastroenterol (2006) 0.98
Disparate cellular basis of improved liver repair in beta-catenin-overexpressing mice after long-term exposure to 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Am J Pathol (2010) 0.96
Keratin 19 marks poor differentiation and a more aggressive behaviour in canine and human hepatocellular tumours. Comp Hepatol (2010) 0.92
Laminin induces the expression of cytokeratin 19 in hepatocellular carcinoma cells growing in culture. World J Gastroenterol (2003) 0.86
Cytokeratin expression patterns in metastatic transitional cell carcinoma of the urinary tract. An immunohistochemical study comparing local tumor and autologous metastases. Am J Pathol (1991) 0.85
A specific distal promoter controls gamma-glutamyl transpeptidase gene expression in undifferentiated rat transformed liver cells. Biochem J (1997) 0.83
Liver stem cells and molecular signaling pathways in hepatocellular carcinoma. Gastrointest Cancer Res (2007) 0.83
The expression of cytokeratin 19 in lymph nodes was a poor prognostic factor for hepatocellular carcinoma after hepatic resection. World J Surg Oncol (2013) 0.81
Intratumoral sampling variability in hepatocellular carcinoma: a case report. World J Gastroenterol (2007) 0.81
Serum CYFRA 21-1 level reflects hepatocellular carcinoma metastasis: study in nude mice model and clinical patients. J Cancer Res Clin Oncol (2006) 0.77
Expression of K19 and K7 in dysplastic nodules and hepatocellular carcinoma. Oncol Lett (2012) 0.76
Persistent effect of mTOR inhibition on preneoplastic foci progression and gene expression in a rat model of hepatocellular carcinoma. Carcinogenesis (2016) 0.76
Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma. Oncotarget (2016) 0.76
Cytokeratin 20-positive hepatocellular carcinoma. Eur J Histochem (2009) 0.75
Ductular reaction, cytokeratin 7 positivity, and gamma-glutamyl transferase in multistage hepatocarcinogenesis in rats. Protoplasma (2016) 0.75
Histological grading and staging of chronic hepatitis. J Hepatol (1995) 19.57
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet (2001) 6.11
A classification of chronic hepatitis. Lancet (1968) 6.07
Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol (2005) 5.27
Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet (2001) 4.66
Outbreake of Marburg virus disease in Johannesburg. Br Med J (1975) 3.51
Malignant angiomyolipoma of the liver: a hitherto unreported variant. Histopathology (2000) 3.24
Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. N Engl J Med (1981) 3.17
Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem (1995) 3.08
Cytogenetic evidence of clonality in cutaneous benign fibrous histiocytomas: a report of the CHAMP study group. Histopathology (2000) 3.05
PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr Biol (1999) 3.05
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene (2001) 2.97
18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec). Eur J Cancer (2003) 2.97
Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha. Biochem J (1998) 2.73
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet (2015) 2.70
Benign intracranial hypertension. II. CSF pressure and circulation. Brain (1974) 2.69
Low fat caries. Br Dent J (1996) 2.64
Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol (2000) 2.56
Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am J Pathol (1996) 2.42
Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients. Gastroenterology (1976) 2.17
Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am J Pathol (1999) 2.12
MRI findings in acute cerebellitis. Eur Radiol (2004) 2.12
Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers. Hepatology (1983) 2.10
Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections. J Hepatol (1997) 1.97
A survey of awareness of radiation dose among health professionals in Northern Ireland. Br J Radiol (2008) 1.80
Benign intracranial hypertension. I. Diagnosis and prognosis. Brain (1974) 1.80
Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. Cancer Genet Cytogenet (1993) 1.77
High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. Hepatology (1999) 1.76
Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. JAMA (1998) 1.76
Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology (1986) 1.75
Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation. Liver Int (2005) 1.74
Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control (2001) 1.74
Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinomas. Hepatology (1981) 1.73
Hepatitis B virus carrier state in black children in Ovamboland: role of perinatal and horizontal infection. Lancet (1984) 1.67
Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J Clin Invest (1999) 1.64
Arthrogryposis, renal dysfunction and cholestasis syndrome: report of five patients from three Italian families. Eur J Pediatr (1995) 1.63
Incomplete septal cirrhosis: histopathological aspects. Histopathology (1988) 1.63
Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet (2003) 1.62
Trisomies 8 and 20 in desmoid tumors. Cancer Genet Cytogenet (1996) 1.61
Renal and intrarenal blood-flow in cirrhosis of the liver. Lancet (1971) 1.60
The development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study. Hepatology (1988) 1.59
Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy. J Viral Hepat (2005) 1.59
Arsenic and non-cirrhotic portal hypertension. A report of eight cases. J Hepatol (1990) 1.59
Phenotypic classes of phenoloxidase-negative mutants of the lignin-degrading fungus Phanerochaete chrysosporium. J Bacteriol (1985) 1.56
Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. J Gen Virol (1995) 1.55
The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host. J Virol (1992) 1.52
Plasmacytoid monocytes (so-called plasmacytoid T cells) in granulomatous lymphadenitis. Hum Pathol (1989) 1.51
Comparison of hepatitis B virus DNA extractions from serum by the QIAamp blood kit, GeneReleaser, and the phenol-chloroform method. J Clin Microbiol (1996) 1.50
Studies in alcoholic liver disease in Britain. I. Clinical and pathological patterns related to natural history. Gut (1974) 1.50
Combined morphologic and karyotypic study of 59 atypical lipomatous tumors. Evaluation of their relationship and differential diagnosis with other adipose tissue tumors (a report of the CHAMP Study Group). Am J Surg Pathol (1996) 1.48
Value of histochemical stains for copper in the diagnosis of Wilson's disease. Histopathology (1998) 1.48
Plasmacytoid T cells. Immunohistochemical evidence for their monocyte/macrophage origin. Am J Pathol (1988) 1.46
Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology (2001) 1.46
Diagnosis of primary cancer of the liver. Br Med J (1971) 1.45
Immunofluorescent detection of hepatitis B antigen in paraffin-embedded liver tissue. J Immunol Methods (1975) 1.44
Pregnancy tests and proteinuria. Lancet (1967) 1.44
Hepatocyte inclusions of alpha 1-antichymotrypsin in a patient with partial deficiency of alpha 1-antichymotrypsin and chronic liver disease. Histopathology (1990) 1.44
Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7. Biochem J (2000) 1.44
Serine 727 phosphorylation and activation of cytosolic phospholipase A2 by MNK1-related protein kinases. J Biol Chem (2000) 1.43
Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons. Am J Pathol (2000) 1.42
Complex tumor-specific t(X;18) in seven synovial sarcoma tumors. Cancer Genet Cytogenet (2009) 1.41
Distribution patterns of hepatitis B surface antigen (HBsAg) in the liver of hepatitis patients. J Clin Pathol (1976) 1.41
Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology (1990) 1.40
Direct surgery in the treatment of posterior communicating aneurysms. Lancet (1968) 1.39
Experimental infection of chimpanzees with hepatitis C virus of genotype 5a: genetic analysis of the virus and generation of a standardized challenge pool. J Infect Dis (1998) 1.38
An update on the careers of dentists undertaking a medical qualification. Br J Oral Maxillofac Surg (1995) 1.38
Inferior vena caval and right atrial thrombosis complicating an amebic hepatic abscess. Am J Gastroenterol (1988) 1.37
Pontomedullary encephalitis and basal meningitis due to Listeria monocytogenes: report of a case. Eur Neurol (1985) 1.36
PLAG1 fusion oncogenes in lipoblastoma. Cancer Res (2000) 1.35
Possible transmission of serum (Australia-antigen-positive) hepatitis via the conjunctiva. Infect Immun (1973) 1.33
Uneven hepatic iron and phosphorus distribution in beta-thalassemia. J Hepatol (1995) 1.33
Histochemistry of gamma-glutamyl transpeptidase in rat liver during aflatoxin B1-induced carcinogenesis. J Natl Cancer Inst (1975) 1.33
The core promoter of hepatitis B virus. J Viral Hepat (1999) 1.33
Administration of human fibroblast interferon in chronic hepatitis-B infection. Lancet (1976) 1.31
A phase II trial with rosiglitazone in liposarcoma patients. Br J Cancer (2003) 1.31
Synovial sarcoma of the larynx and hypopharynx. Ann Otol Rhinol Laryngol (1998) 1.31
Collagenous colitis: an abnormal collagen table? Two new cases and review of the literature. Am J Gastroenterol (1982) 1.30
Baseline epidemiological studies for a hepatitis B vaccine trial in Kangwane. S Afr Med J (1983) 1.29
Neuroendocrine features of reactive bile ductules in cholestatic liver disease. Am J Pathol (1990) 1.28
Intrahepatic bile duct development in the rat: a cytokeratin-immunohistochemical study. Lab Invest (1988) 1.27
In situ distribution of major histocompatibility complex products and viral antigens in chronic hepatitis B virus infection: evidence that HBc-containing hepatocytes may express HLA-DR antigens. Hepatology (1986) 1.24
Assessment of psychological distress in prospective bone marrow transplant patients. Bone Marrow Transplant (2002) 1.23
A cytokeratin immunohistochemical study of cholestatic liver disease: evidence that hepatocytes can express 'bile duct-type' cytokeratins. Histopathology (1989) 1.23
The effects of heatstroke on the function and structure of the kidney. Q J Med (1967) 1.22
Intrahepatic bile ducts under the lens. J Hepatol (1985) 1.22
Aneurysmal bone cyst of the nose with 17p13 involvement. Virchows Arch (2001) 1.21
Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile ducts and acinar gradient. Virchows Arch A Pathol Anat Histopathol (1987) 1.21
Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases. Hepatology (1988) 1.20
Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group. Curr Oncol (2008) 1.20
A unique segment of the hepatitis B virus group A genotype identified in isolates from South Africa. J Gen Virol (1997) 1.19
Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group. Am J Pathol (1999) 1.19
Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group. J Pathol (2000) 1.18
Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis (1984) 1.18
Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. J Infect Dis (2000) 1.18